Country: Israel
Language: English
Source: Ministry of Health
LABETALOL HYDROCHLORIDE
PADAGIS ISRAEL AGENCIES LTD, ISRAEL
C07AG01
TABLETS
LABETALOL HYDROCHLORIDE 100 MG
PER OS
Required
ASPEN BAD OLDESLOE GMBH, GERMANY
LABETALOL
LABETALOL
Treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.
2021-11-30
ةيبناجلا ضارعلأا )4 .نيلمعتسملا ضعب دنع ةيبناج ً اضارعأ ببسي دق تدنارت لامعتسإ نإ ،ءاود لكب امك .اهنم ً ايأ يناعت لاأ زئاجلا نم .ةيبناجلا ضارعلأا ةمئاق نم شهدنت لا ً ادج ةردان( ةيلاتلا ضارعلأا ىدحإ ترهظ اذإ بيبطلل ً لااح هجوتلا بجي :)10 ٬ 000 نيب نم دحاو لمعتسم نم لقأ ىدل رهظتو حفط ،ةنوخس ،لصافملا يف ملاآ :لثم ضارعأ ىلإ يدؤت ةيزاهج ةيرارمحإ ةبئذ ● قاهرإو يدلج ةرابع ةلاحلا هذه( ةيلوبلا ةناثملا ءلاتمإ نم مغرلاب لوبتلا ىلع ةماتلا ةردقلا مدع ● )ةئراط ةيبط ةلاح نع خافتنإ لمشت يتلا ضارعأ ىلإ يدؤت نأ نكمي يتلا )ةيسسحت ةمذو( ةيئاعو ةمذو ● سفنتلا يف تابوعص ىلإ يدؤت دق يتلا ،ناسللا يفو هجولا يف ،نيتفشلا يف ةيفاضإ ةيبناج ضارعأ نم رثكأ ىدل رهظت ـ )very common( ً ادج ةعئاش ةيبناج ضارعأ :ةرشع نم دحاو لمعتسم .ضرملاب ةقلاع اهل سيل دادضأ ● نيلمعتسم 1-10 ىدل رهظت ـ )common( ةعئاش ةيبناج ضارعأ :100 نيب نم بلقلا روصق ● دعب ةميلس حبصتل ميقلا هذه دوعت ةداع .دبكلا فئاظو صوحفل ةعفترم ميق ● ءاودلاب جلاعلا نع فقوتلا نأ نكميو ةتقؤم نوكت ةداع يتلا ،سأرلا ةورف يف زخوب روعشو عادص ،راود ● جلاعلا نم ىلولأا عيباسلأا للاخ رهظت ةيؤرلا شوشت ● لوبتلا يف تابوعص ● يغبني امم عرسأ لكشب ضوهنلا دنع مدلا طغض يف ضافخنإ ءارج راود ● postural( فوقولا ىلإ سولجلا نم وأ سولجلا ىلإ ءاقلتسلإ Read the complete document
Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Trandate tablets 100 mg Trandate tablets 200 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains 100 mg or 200 mg respectively of labetalol hydrochloride. Excipient with known effect: 100 mg: Each film-coated tablet contains 14.6 mg anhydrous lactose, 1.15 microgram sodium benzoate and 17.2 microgram sunset yellow (E110). 200mg: Each film-coated tablet contains 29.3 mg anhydrous lactose, 2.3 microgram sodium benzoate and 34.4 microgram sunset yellow (E110). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet _100 mg: _ Orange, round, biconvex, engraved TT01 on one face. _200 mg: _ Orange, round, biconvex, engraved TT02 on one face. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY POPULATIONS • ADULTS: Mild, moderate or severe hypertension - Treatment should be initiated with 100 mg twice daily. If required, the dose can be increased by 100 mg twice daily at an interval of 2-14 days. Many patients achieve blood pressure control with a dose of 200 mg twice daily; up to 800 mg daily can be given as two divided doses. In case of severe refractory hypertension, daily doses of up to 2400 mg have been given as three or four divided doses. The dose administered to patients hospitalised with severe hypertension can be increased on a daily basis. Page 2 of 12 Further blood pressure lowering effects should be expected if labetalol tablets are administered concomitantly with other blood pressure lowering drugs such as diuretics, methyldopa etc. When patients switch from drugs such as these, labetalol tablets should be introduced with a dosage of 100mg twice daily and the previous therapy should be phased out gradually. Abrupt withdrawal of clonidine or beta-blocking agents is undesirable. For long-term control of hypertensi Read the complete document